![Magnus Hansson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Magnus Hansson
Technik-/Wissenschafts-/F&E-Leiter bei
ABLIVA AB
Profil
Magnus Hansson is currently the Chief Medical Officer & VP-Preclinical Development at Abliva AB since 2016.
Previously, he worked as an Associate Professor at Skane University Hospital from 2008 to 2015.
Dr. Hansson obtained a doctorate degree from the University of Lund.
Aktive Positionen von Magnus Hansson
| Unternehmen | Position | Beginn |
|---|---|---|
| ABLIVA AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
Ehemalige bekannte Positionen von Magnus Hansson
| Unternehmen | Position | Ende |
|---|---|---|
Skane University Hospital
 Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Corporate Officer/Principal | 01.12.2015 |
Ausbildung von Magnus Hansson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Operates as an hospital | Health Services |
